Cargando…
Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature
BACKGROUND: Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma in adults. Metabolic reprogramming in tumors is closely related to the immune microenvironment. This study aimed to explore the interactions between metabolism-associated genes (MAGs) and DLBCL prognosis and their potentia...
Autores principales: | He, Jing, Chen, Ziwei, Xue, Qingfeng, Sun, Pingping, Wang, Yuan, Zhu, Cindy, Shi, Wenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036805/ https://www.ncbi.nlm.nih.gov/pubmed/35468826 http://dx.doi.org/10.1186/s12967-022-03393-9 |
Ejemplares similares
-
Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
por: Wang, Huizhong, et al.
Publicado: (2021) -
Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2019) -
Identification of a 14-Gene Prognostic Signature for Diffuse Large B Cell Lymphoma (DLBCL)
por: Feng, Pengcheng, et al.
Publicado: (2021) -
Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma
por: Leivonen, S-K, et al.
Publicado: (2017) -
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
por: Kim, Eugene, et al.
Publicado: (2022)